PARTNER
At ICON we have built our reputation on enduring partnerships that are driven to advance medicine and make a difference in the world.
ICON is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.
With headquarters in Dublin, Ireland, ICON currently operates from 94 locations in 40 countries and has approximately 15,250 employees.
DISCOVER MORE
DOWNLOAD & LEARN MORE
CONTACT ICON
Harold Schmidt
Vice President Business Development
ICON CLINICAL RESEARCH
For more information on partnership opportunities please contact Joe Hames on joe.hames@ft.com
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice